Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Gross Margin (2020 - 2026)

NeuroPace has reported Gross Margin over the past 7 years, most recently at 81.78% for Q1 2026.

  • For Q1 2026, Gross Margin rose 479.0% year-over-year to 81.78%; the TTM value through Mar 2026 reached 78.29%, up 347.0%, while the annual FY2025 figure was 77.23%, 329.0% up from the prior year.
  • Gross Margin for Q1 2026 was 81.78% at NeuroPace, up from 77.4% in the prior quarter.
  • Over five years, Gross Margin peaked at 81.78% in Q1 2026 and troughed at 68.83% in Q4 2022.
  • A 5-year average of 74.48% and a median of 73.62% in 2024 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: plummeted -461bps in 2022 and later skyrocketed 637bps in 2023.
  • Year by year, Gross Margin stood at 68.83% in 2022, then rose by 9bps to 75.2% in 2023, then rose by 0bps to 75.41% in 2024, then rose by 3bps to 77.4% in 2025, then rose by 6bps to 81.78% in 2026.
  • Business Quant data shows Gross Margin for NPCE at 81.78% in Q1 2026, 77.4% in Q4 2025, and 77.39% in Q3 2025.